These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 817868)

  • 21. The influence of renal function on plasma levels, urinary excretion, metabolism, and antihypertensive effect of guanethidine (ismelin) in man.
    Rahn KH
    Clin Nephrol; 1973; 1(1):14-23. PubMed ID: 4767350
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The combination of guanethidine and hydrochlorothiazide in the treatment of arterial hypertension with and without renal failure.
    Muiesan G; Motolese M; Petz E; Todisco T
    Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):489-94. PubMed ID: 4887948
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical assessment of the new antihypertensive Compound--1029 (Vatensol)--Guanoclor.
    Mehta AB; Biswas AK; Pinto IJ; Sheth UK
    Indian Heart J; 1967 Oct; 19(4):322-8. PubMed ID: 4870898
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparative clinical trial of guanoxan and guanethidine in essential hypertension.
    Ruedy J; Davies RO
    Clin Pharmacol Ther; 1967; 8(1):38-47. PubMed ID: 5334083
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical study of guanoxan in the treatment of hypertension.
    Krishnankutty PK; Krishnamurthi TN
    Indian Heart J; 1968 Apr; 20(2):165-73. PubMed ID: 4902803
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypertension. II.
    Br Med J; 1971 Jan; 1(5740):99-101. PubMed ID: 4395327
    [No Abstract]   [Full Text] [Related]  

  • 29. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
    Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of guanethidine and reserpine in angiotensin sensitivity in man].
    Kállay K; Káldor A; Gachályi B; Sebestyén K; Földvári A
    Orv Hetil; 1974 Dec; 115(49):2917-9. PubMed ID: 4376593
    [No Abstract]   [Full Text] [Related]  

  • 31. Further observations on a new antihypertensive Vatensol (Compound 1029).
    Srivastava BN; Vyas GP; Tiwari AK; Tapa RS; Nema HS
    Indian Heart J; 1967 Oct; 19(4):329-35. PubMed ID: 4870899
    [No Abstract]   [Full Text] [Related]  

  • 32. [A new antihypertensive agent used in a clinical setting].
    Wetzels E; Raschig A; Kaiser HJ
    Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on hemodynamics after intravenous application of dihydralazine and guanethidine in hypertonic patients].
    Juchems R; Ammerschläger G
    Arzneimittelforschung; 1967 May; 17(5):587-91. PubMed ID: 4873896
    [No Abstract]   [Full Text] [Related]  

  • 34. The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents.
    Oates JA; Seligmann AW; Clark MA; Rousseau P; Lee RE
    N Engl J Med; 1965 Sep; 273(14):729-34. PubMed ID: 5317954
    [No Abstract]   [Full Text] [Related]  

  • 35. [Guanfacine in primary arterial hypertension: a long-term open clinical study].
    Román O; Valenzuela MA; Salazar R
    Rev Med Chil; 1982 Dec; 110(12):1179-84. PubMed ID: 6764015
    [No Abstract]   [Full Text] [Related]  

  • 36. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG; Bloxham CA; Walker JM
    Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guanethidine in hypertension.
    Brahma SK; Chowdhury B; Sarkar BK; De MK; Dutta PK
    J Indian Med Assoc; 1966 May; 46(10):541-3. PubMed ID: 5329978
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical evaluation of guanethidine in hypertension].
    Kocemba J; Mareczek S; Smoroń A
    Wiad Lek; 1968 May; 21(9):731-7. PubMed ID: 4875996
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of alpha-methyl-dopa (Dopegyt) and other antihypertensive drugs (guanethidine, bethanidine) on the isotope renogram.
    Radó J; Bános C; Takó J; Szabó T; Borbély L; Szende L; Kapus I; Nagy M
    Ther Hung; 1969; 17(2):76-82. PubMed ID: 5807612
    [No Abstract]   [Full Text] [Related]  

  • 40. Guanethidine in antihypertensive therapy: experience with an oral loading regimen.
    McAllister RG
    J Clin Pharmacol; 1975; 15(11-12):771-8. PubMed ID: 1104667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.